PTGER3 encodes a receptor for prostaglandin E2 that is targeted by misoprostol, an approved drug for gastric ulcers and reflux disease and which has shown efficacy in colon cancer xenograft models62. Here, PTGER3 is linked to malignant colon neoplasm.